A combination vaccine against the coronavirus and flu, which was developed by the American pharmaceutical giant Pfizer and its German partner BioNTech, has been included in an accelerated approval procedure by the American drug watchdog FDA. Pfizer and BioNTech announced this local time on Friday.
ttn-3
Accelerated approval procedure for combination vaccine against corona and flu in US
